NNelo Trade
← Back to Market News
September 25, 2026 at 09:40 PM UTC

INTEGRATED BIOPHARMA INC reports financial results in SEC 8-K

INTEGRATED BIOPHARMA INC filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: September 25, 2026 at 09:05 PM UTC

Open official source
INTEGRATED BIOPHARMA INC reports financial results in SEC 8-K | Nelo Trade